NMTC · NEUROONE MEDICAL TECHNOLOGIES Corp · Proposed Sales
$0.97
+0.11 (+12.96%)
At close · Oct 29
Return incl. dividend (before tax)
Q3 2026 earnings call transcript
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 13, 2026
Market Cap
$7.82M
Shares
9.11M
Volume · Oct 29
66.81K
Avg daily vol (3M)
342.04K
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
| Filed | Seller | Relationship | Shares | Approx. Sale | Broker |
|---|---|---|---|---|---|
| 2026-06-30 | Christianson Mark | Officer | 10,000 | 2026-06-30 | Edward Jones |
| 2026-03-09 | Christianson Mark | Officer | 30,000 | 2026-03-09 | Edward Jones |
| 2025-08-20 | Christianson Mark | Officer | 30,000 | 2025-08-20 | Edward Jones |
| 2025-03-14 | Christianson Mark | Co-Founder, VP of Business Communication,Affiliate | 30,000 | 2025-03-14 | Edward Jones |
| 2024-05-24 | Christianson Mark | co-founder, VP of Business Communication, Affiliat | 30,000 | 2024-05-24 | Edward Jones |
| 2023-12-21 | Christianson Mark | Officer | 50,000 | 2023-12-21 | Edward Jones |
Showing 1–6 of 6 filings